Johnson & Johnson will pay less money for an equity stake in Elan Corporation Plc after a US court ruled that a proposed partnership between the two companies was in conflict with a separate collaboration between Elan and Biogen Idec.
Johnson & Johnson will pay less money for an equity stake in Elan Corporation Plc after a US court ruled that a proposed partnership between the two companies was in conflict with a separate collaboration between Elan and Biogen Idec.